Methods	Method	NNS	B-NP	O		0	7
for	for	IN	B-PP	O		8	11
the	the	DT	B-NP	O		12	15
detection	detection	NN	I-NP	O		16	25
of	of	IN	B-PP	O		26	28
a	a	DT	B-NP	O		29	30
specific	specific	JJ	I-NP	B-protein		31	39
Mycobacterium leprae	Mycobacterium_leprae	NNP	I-NP	I-protein		40	60
antigen	antigen	NN	I-NP	I-protein		61	68
in	in	IN	B-PP	O		69	71
the	the	DT	B-NP	O		72	75
urine	urine	NN	I-NP	O		76	81
of	of	IN	B-PP	O		82	84
leprosy	leprosy	JJ	B-NP	O		85	92
patients	patient	NNS	I-NP	O		93	101
.	.	.	O	O		101	102

Two	Two	CD	B-NP	O		103	106
methods	method	NNS	I-NP	O		107	114
for	for	IN	B-PP	O		115	118
detecting	detect	VBG	B-VP	O		119	128
the	the	DT	B-NP	O		129	132
phenolic	phenolic	JJ	I-NP	O		133	141
glycolipid	glycolipid	NN	I-NP	O		142	152
,	,	,	O	O		152	153
PGL	PGL	NN	B-NP	B-protein		154	157
-1	-1	NN	I-NP	I-protein		157	159
,	,	,	O	O		159	160
a	a	DT	B-NP	O		161	162
Mycobacterium leprae	Mycobacterium_leprae	NNP	I-NP	O		163	183
-	-	HYPH	I-NP	O		183	184
specific	specific	JJ	I-NP	O		184	192
molecule	molecule	NN	I-NP	O		193	201
,	,	,	O	O		201	202
in	in	IN	B-PP	O		203	205
the	the	DT	B-NP	O		206	209
urine	urine	NN	I-NP	O		210	215
of	of	IN	B-PP	O		216	218
leprosy	leprosy	JJ	B-NP	O		219	226
patients	patient	NNS	I-NP	O		227	235
are	be	VBP	B-VP	O		236	239
described	describe	VBN	I-VP	O		240	249
.	.	.	O	O		249	250

Both	Both	DT	B-NP	O		251	255
methods	method	NNS	I-NP	O		256	263
rely	rely	VBP	B-VP	O		264	268
on	on	IN	B-PP	O		269	271
the	the	DT	B-NP	O		272	275
100-fold	100-fold	JJ	I-NP	O		276	284
preconcentration	preconcentration	NN	I-NP	O		285	301
of	of	IN	B-PP	O		302	304
the	the	DT	B-NP	O		305	308
urine	urine	NN	I-NP	O		309	314
,	,	,	O	O		314	315
which	which	WDT	B-NP	O		316	321
can	can	MD	B-VP	O		322	325
be	be	VB	I-VP	O		326	328
accomplished	accomplish	VBN	I-VP	O		329	341
by	by	IN	B-PP	O		342	344
a	a	DT	B-NP	O		345	346
single	single	JJ	I-NP	O		347	353
-	-	HYPH	I-NP	O		353	354
step	step	NN	I-NP	O		354	358
ultrafiltration	ultrafiltration	NN	I-NP	O		359	374
procedure	procedure	NN	I-NP	O		375	384
.	.	.	O	O		384	385

The	The	DT	B-NP	O		386	389
equivalent	equivalent	NN	I-NP	O		390	400
of	of	IN	B-PP	O		401	403
approximately	approximately	RB	B-NP	O		404	417
2.5	2.5	CD	I-NP	O		418	421
micrograms	microgram	NNS	I-NP	O		422	432
of	of	IN	B-PP	O		433	435
PGL	PGL	NN	B-NP	B-protein		436	439
-1	-1	NN	I-NP	I-protein		439	441
/	/	SYM	B-NP	O		441	442
ml	ml	NN	I-NP	O		442	444
was	be	VBD	B-VP	O		445	448
detected	detect	VBN	I-VP	O		449	457
in	in	IN	B-PP	O		458	460
the	the	DT	B-NP	O		461	464
urine	urine	NN	I-NP	O		465	470
of	of	IN	B-PP	O		471	473
LL	LL	NN	B-NP	O		474	476
patients	patient	NNS	I-NP	O		477	485
with	with	IN	B-PP	O		486	490
an	an	DT	B-NP	O		491	493
inhibition	inhibition	NN	I-NP	O		494	504
ELISA	ELISA	NN	I-NP	O		505	510
.	.	.	O	O		510	511

The	The	DT	B-NP	O		512	515
second	second	JJ	I-NP	O		516	522
method	method	NN	I-NP	O		523	529
,	,	,	O	O		529	530
a	a	DT	B-NP	O		531	532
direct	direct	JJ	I-NP	O		533	539
dot-blot	dot-blot	NN	I-NP	O		540	548
assay	assay	NN	I-NP	O		549	554
on	on	IN	B-PP	O		555	557
nitrocellulose	nitrocellulose	NN	B-NP	O		558	572
paper	paper	NN	I-NP	O		573	578
,	,	,	O	O		578	579
was	be	VBD	B-VP	O		580	583
much	much	RB	B-ADJP	O		584	588
simpler	simple	JJR	I-ADJP	O		589	596
and	and	CC	O	O		597	600
more	more	RBR	B-ADJP	O		601	605
sensitive	sensitive	JJ	I-ADJP	O		606	615
.	.	.	O	O		615	616

As	As	RB	B-NP	O		617	619
little	little	JJ	I-NP	O		620	626
as	as	IN	I-NP	O		627	629
3	3	CD	I-NP	O		630	631
ng	ng	NN	I-NP	O		632	634
of	of	IN	B-PP	O		635	637
antigen	antigen	NN	B-NP	O		638	645
was	be	VBD	B-VP	O		646	649
detected	detect	VBN	I-VP	O		650	658
by	by	IN	B-PP	O		659	661
the	the	DT	B-NP	O		662	665
dot-blot	dot-blot	NN	I-NP	O		666	674
technique	technique	NN	I-NP	O		675	684
.	.	.	O	O		684	685

PGL	PGL	NN	B-NP	B-protein		686	689
-1	-1	NN	I-NP	I-protein		689	691
was	be	VBD	B-VP	O		692	695
detected	detect	VBN	I-VP	O		696	704
in	in	IN	B-PP	O		705	707
the	the	DT	B-NP	O		708	711
urine	urine	NN	I-NP	O		712	717
of	of	IN	B-PP	O		718	720
LL	LL	NN	B-NP	O		721	723
patients	patient	NNS	I-NP	O		724	732
.	.	.	O	O		732	733

